1.15TWD
115.78 MTWD
1.68 BTWD
90.12 M
About APEX BIOTECHNOLOGY CORP
Sector
Industry
CEO
Yan Shih Shen
Website
Headquarters
Hsinchu
Founded
1997
ISIN
TW0001733004
FIGI
BBG000BK0YZ9
Apex Biotechnology Corp. engages in the business of research, development, production, manufacturing, and selling biochemical testing instruments and detection strips; and trading relevant products and components. It operates through the following geographical segments: Taiwan, the United States of America, Italy, Austria, China, and Others. The company was founded on December 2, 1997 and is headquartered in Hsinchu, Taiwan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1733 is 33.60 TWD — it has increased by 0.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange APEX BIOTECHNOLOGY CORP stocks are traded under the ticker 1733.
APEX BIOTECHNOLOGY CORP is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
1733 stock is 2.39% volatile and has beta coefficient of 0.46. Check out the list of the most volatile stocks — is APEX BIOTECHNOLOGY CORP there?
1733 earnings for the last quarter are 0.28 TWD per share, whereas the estimation was 0.47 TWD resulting in a −40.43% surprise. The estimated earnings for the next quarter are 0.32 TWD per share. See more details about APEX BIOTECHNOLOGY CORP earnings.
APEX BIOTECHNOLOGY CORP revenue for the last quarter amounts to 542.00 M TWD despite the estimated figure of 573.00 M TWD. In the next quarter revenue is expected to reach 461.00 M TWD.
Yes, you can track APEX BIOTECHNOLOGY CORP financials in yearly and quarterly reports right on TradingView.
1733 stock has fallen by 0.44% compared to the previous week, the month change is a 1.61% fall, over the last year APEX BIOTECHNOLOGY CORP has showed a 24.44% increase.
1733 net income for the last quarter is 15.17 M TWD, while the quarter before that showed 37.86 M TWD of net income which accounts for −59.94% change. Track more APEX BIOTECHNOLOGY CORP financial stats to get the full picture.
Today APEX BIOTECHNOLOGY CORP has the market capitalization of 3.34 B, it has decreased by 0.89% over the last week.
Yes, 1733 dividends are paid annually. The last dividend per share was 1.40 TWD. As of today, Dividend Yield (TTM)% is 4.19%. Tracking APEX BIOTECHNOLOGY CORP dividends might help you take more informed decisions.
APEX BIOTECHNOLOGY CORP dividend yield was 2.73% in 2023, and payout ratio reached 94.96%. The year before the numbers were 5.48% and 76.97% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 1733 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APEX BIOTECHNOLOGY CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So APEX BIOTECHNOLOGY CORP technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating APEX BIOTECHNOLOGY CORP stock shows the buy signal. See more of APEX BIOTECHNOLOGY CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on APEX BIOTECHNOLOGY CORP future price: according to them, 1733 price has a max estimate of 35.00 TWD and a min estimate of 35.00 TWD. Read a more detailed APEX BIOTECHNOLOGY CORP forecast: see what analysts think of APEX BIOTECHNOLOGY CORP and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. APEX BIOTECHNOLOGY CORP EBITDA is 217.43 M TWD, and current EBITDA margin is 12.97%. See more stats in APEX BIOTECHNOLOGY CORP financial statements.